 Genotype
"Genotype" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.
| Descriptor ID |
D005838
|
| MeSH Number(s) |
G05.380
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Genotype".
Below are MeSH descriptors whose meaning is more specific than "Genotype".
This graph shows the total number of publications written about "Genotype" by people in this website by year, and whether "Genotype" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 8 | 9 | | 1999 | 0 | 2 | 2 | | 2000 | 0 | 3 | 3 | | 2001 | 0 | 3 | 3 | | 2002 | 0 | 4 | 4 | | 2003 | 0 | 8 | 8 | | 2004 | 0 | 6 | 6 | | 2005 | 0 | 7 | 7 | | 2006 | 0 | 6 | 6 | | 2007 | 0 | 12 | 12 | | 2008 | 0 | 12 | 12 | | 2009 | 0 | 9 | 9 | | 2010 | 0 | 21 | 21 | | 2011 | 0 | 21 | 21 | | 2012 | 0 | 17 | 17 | | 2013 | 0 | 19 | 19 | | 2014 | 1 | 21 | 22 | | 2015 | 1 | 21 | 22 | | 2016 | 3 | 18 | 21 | | 2017 | 3 | 9 | 12 | | 2018 | 3 | 14 | 17 | | 2019 | 0 | 12 | 12 | | 2020 | 0 | 8 | 8 | | 2021 | 2 | 15 | 17 | | 2022 | 0 | 11 | 11 | | 2023 | 0 | 10 | 10 | | 2024 | 2 | 13 | 15 |
To return to the timeline, click here.
Below are the most recent publications written about "Genotype" by people in Profiles.
-
Bishop JR, Zhou C, Gaedigk A, Krone B, Kittles R, Cook EH, Newcorn JH, Stein MA. Dopamine Transporter and CYP2D6 Gene Relationships with Attention-Deficit/Hyperactivity Disorder Treatment Response in the Methylphenidate and Atomoxetine Crossover Study. J Child Adolesc Psychopharmacol. 2024 12; 34(10):458-469.
-
Langlois AWR, Chenoweth MJ, Twesigomwe D, Scantamburlo G, Whirl-Carrillo M, Sangkuhl K, Klein TE, Nofziger C, Tyndale RF, Gaedigk A. PharmVar GeneFocus: CYP2A6. Clin Pharmacol Ther. 2024 Oct; 116(4):948-962.
-
Pratt VM, Cavallari LH, Fulmer ML, Gaedigk A, Hachad H, Ji Y, Kalman LV, Ly RC, Moyer AM, Scott SA, Turner AJ, van Schaik RHN, Whirl-Carrillo M, Weck KE. DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium. J Mol Diagn. 2024 Oct; 26(10):851-863.
-
Parvez MM, Thakur A, Mehrotra A, Stancil S, Pearce RE, Basit A, Leeder JS, Prasad B. Age-Dependent Abundance of CYP450 Enzymes Involved in Metronidazole Metabolism: Application to Pediatric PBPK Modeling. Clin Pharmacol Ther. 2024 Oct; 116(4):1090-1099.
-
Duarte JD, Thomas CD, Lee CR, Huddart R, Agundez JAG, Baye JF, Gaedigk A, Klein TE, Lanfear DE, Monte AA, Nagy M, Schwab M, Stein CM, Uppugunduri CRS, van Schaik RHN, Donnelly RS, Caudle KE, Luzum JA. Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC)?for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy. Clin Pharmacol Ther. 2024 Oct; 116(4):939-947.
-
Robinson KM, Eum S, Desta Z, Tyndale RF, Gaedigk A, Crist RC, Haidar CE, Myers AL, Samer CF, Somogyi AA, Zubiaur P, Iwuchukwu OF, Whirl-Carrillo M, Klein TE, Caudle KE, Donnelly RS, Kharasch ED. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy. Clin Pharmacol Ther. 2024 Oct; 116(4):932-938.
-
Sasidharan A, Harrison CJ, Selvarangan R. Diagnosis, management, and outcomes of parechovirus infections in infants: an overview. J Clin Microbiol. 2024 Jun 12; 62(6):e0113923.
-
Kyler KE, Gaedigk A, Abdel-Rahman S, Staggs VS, Pearce RE, Toren P, Leeder JS, Shakhnovich V. Influence of novel CYP2C-haplotype on proton pump inhibitor pharmacokinetics in children. Clin Transl Sci. 2024 04; 17(4):e13782.
-
Gaedigk A, Turner AJ, Haidar CE, Empey PE, Offer SM. Response to "DPYD genotyping panels: Impact of population diversity". Clin Transl Sci. 2024 Apr; 17(4):e13806.
-
Honeycutt DC, Blom TJ, Ramsey LB, Strawn JR, Bruns KM, Welge JA, Patino LR, Singh MK, DelBello MP. Pharmacogenetic Factors Influence Escitalopram Pharmacokinetics and Adverse Events in Youth with a Family History of Bipolar Disorder: A Preliminary Study. J Child Adolesc Psychopharmacol. 2024 02; 34(1):42-51.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|